ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645017 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645017; 2) Community: the network communities that were significantly associated with the response to NSC 645017; 3) Molecule: the relationships between components within communities and NSC 645017; 4) MDR: the compounds that were significantly associated with the NSC 645017.

NSC Compound Enrichment Correlation
NSC 741106 6-(3-Aminopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0137891122538509 0.617438
NSC 746930 Null 0.0137891122538509 0.20434932
NSC 748512 Null 0.0137891122538509 0.028633843
NSC 7521 [(6-Deoxy-.alpha.-L-mannopyranosyl)oxy]-14-hydroxybufa-4,20,22-trienolide 0.0137891122538509 0.39700927
NSC 753664 Null 0.0137891122538509 0.11065855
NSC 100880 Camptothecin 0.013789112253851 0.72710392
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.013789112253851 0.36626713
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.013789112253851 0.059518298
NSC 18805 .gamma.-Thujaplicine 0.013789112253851 0.28352198
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.013789112253851 0.14347523
Total:106  Current:44    [First] [Prev] [Next] [Last]